Health Research & Analysis

Inflexxion's drug abuse surveillance and risk analysis services offer post-marketing surveillance to support risk management as well as epidemiological studies required for FDA-regulated products (i.e., pharmaceutical & tobacco products) that have abuse potential and may pose health dangers. Using proprietary and publicly available data streams, Inflexxion's team of epidemiologists, social scientists, and statistical experts work with industry, the FDA, payors and other stakeholders to advance public health by empirically monitoring and investigating usage patterns. These include trends in use and abuse of prescription medications and illegal drugs as well as use patterns of novel tobacco products (NTPs).

We provide routine reporting on patterns and trends of prescription medication abuse to achieve FDA compliance and support FDA post-market surveillance requirements, as well as monitoring and analyses of emerging trends in substance abuse in collaboration with public health authorities, risk management professionals, and behavioral health stakeholders. Tailored, post-marketing epidemiology studies help to support labeling claims. Inflexxion's scientific and statistical skills, knowledge and experience are uniquely suited to help navigate the challenges of risk management in the regulatory environment. Inflexxion has more than 10 years of experience in working with companies who manufacture/market regulated products with abuse or addictive potential. Let us help you meet the complex requirements of healthcare and regulatory systems.

Our Services

What our customers are saying

Inflexxion has completed 2 projects with us already, and we've continued exploring what else we can do with them because we've been very happy with the work."

- Pharmaceutical company

They don't just take existing data and try to tease out what we need, they work with us to formulate some surveys and get some truly new data."

- Pharmaceutical company